01 May 2024 --- Plant cell technology company Ayana Bio will use the US$300,000 grant to support its research into the neuroprotective benefits of saffron for Huntington’s disease and other neurological and age-related diseases. Specifically, the grant from the US National Center for Complementary and Integrative Health, part of the National Institutes of Health (NIH), will fund the company’s research to identify which complex of saffron bioactives can consistently demonstrate the highest neuroprotective benefits for the disease.